PharmGen Science Market Cap

PharmGen Science has a market cap or net worth of 80.26 billion as of February 21, 2025. Its market cap has decreased by -26.85% in one year.

Market Cap

80.26B

Enterprise Value

84.66B

Revenue

173.60B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,320.00

Market Cap Chart

Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 80.26B, an increase of 636.92%. That is a compound annual growth rate of 7.01%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	80.26B	8.20%
Dec 30, 2024	74.18B	-33.39%
Dec 28, 2023	111.36B	5.58%
Dec 29, 2022	105.47B	-33.88%
Dec 30, 2021	159.51B	-3.78%
Dec 30, 2020	165.78B	123.51%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	82.28T
Celltrion	38.31T
SK Biopharmaceuticals	9,327.11B
Yuhan	9,148.44B
SK bioscience	3,760.67B
Hanmi Pharm.	3,436.34B
Hanmi Science	1,956.93B
Hanall Biopharma	1,934.60B

Market Cap Rankings